Alzheimer's Drug Discovery Foundation logo
Program

Drug Development RFP

Funds early-stage drug development and first human testing for Alzheimer's disease and related dementias.

The Drug Development RFP is Alzheimer's Drug Discovery Foundation's flagship therapeutics program and a core route under the foundation's mission-related investment model. It supports work on Alzheimer's disease and related dementias, with a clear emphasis on translational drug development rather than broad basic science. The program sits inside ADDF's larger portfolio of drug, biomarker, and prev

BiotechMedtech

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.

Last verified: 28 May 2026Source: www.alzdiscovery.org